---
title: "Bolt Biotherapeutics soars 57% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302892427.md"
description: "Bolt Biotherapeutics rose 56.76% to US$6.568. Up 64.21% over five sessions."
datetime: "2026-10-23T13:55:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302892427.md)
  - [en](https://longbridge.com/en/news/302892427.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302892427.md)
generator: "portal-rs"
---

# Bolt Biotherapeutics soars 57% during regular trading

Bolt Biotherapeutics (BOLT.US) soared nearly **57%** during regular trading to **$6.568**.

The stock is up 64.21% over the past five sessions and sits 111.87% above its 52-week low of US$3.100.

The Nasdaq Composite is down 0.66% over the past five sessions and up 11.73% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [BOLT.US](https://longbridge.com/en/quote/BOLT.US.md)

## Related News & Research

- [Bolt, Stellantis plan autonomous driving experiment in Greater Paris from 2028](https://longbridge.com/en/news/302864321.md)
- [Bolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01](https://longbridge.com/en/news/299687685.md)
- [Amazon.com, Inc. $AMZN Stock Sold by Cohen Klingenstein LLC](https://longbridge.com/en/news/302980467.md)
- [Google's privacy policy lets connected Gmail and Photos data personalize ads](https://longbridge.com/en/news/302987424.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**